A Single Center Experience of Stenting in Symptomatic Intracranial Atherosclerosis

Abstract

Atherosclerotic intracranial arterial stenosis is an important cause of stroke that is increasingly being treated with percutaneous transluminal angioplasty and stenting (PTAS) to prevent recurrent stroke. However, PTAS has been compared with medical management in a randomized trial (SAMMPRIS), where aggressive medical management was superior to PTAS with the use of the Wingspan stent system, however in our experience we have had good results and have experienced no complications with this therapy. In a retrospective, single-center study we enrolled seven consecutive patients with a symptomatic angiographically proven atherosclerotic intracranial arterial stenosis of the anterior and posterior circulation. All cases received adjuvant therapy (aspirin and clopidogrel or ticlopidine) before and after deployment of the device. The procedures were performed with the patient under general anesthesia. We use the Wingspan stent system. The occlusion site was middle cerebral artery (MCA) in three patients, proximal internal carotid artery (ICA) in one patient and vertebrobasilar artery in three patients. Primary interventional successful revascularization was achieved in all cases. Four patients had no residual stenosis, and the other three had 20%, 30% and 40% residual stenosis (Table 1). All patients showed a clinical improvement after stent deployment. No peri-interventional events or neurologic complications occurred directly related to the technique. Patency rate was 100% at the last examination in six cases, one case had a pre-occlusive stenosis, requiring angioplasty. No patients died during the follow-up period, and 100% of patients showed good functional outcome at three months (modified Rankin Scale score ≤ 2). Although the SAMMPRIS study showed that aggressive medical management was superior to PTAS, our results suggest that intracranial stenting is safe and effective, probably due to an extraordinary selection of candidates and to an exquisite technique.

Keywords

intracranial stenting stroke interventional neuroradiology

Get full access to this article

View all access options for this article.

References

Eberhardt

Naegele

Raygrotzki

. Stenting of vertebrobasilar arteries in symptomatic atherosclerotic disease and acute occlusion: Case series and review of the literature. J Vasc Surg. 2006; 43: 1145–1154.

du Mesnil de Rochemont

Turowski

Buchkremer

. Recurrent symptomatic high-grade intracranial stenoses: Safety and efficacy of undersized stents - initial experience. Radiology. 2004; 231: 45–49.

Levy

Boulos

Guterman

. Stent-assisted endoluminal revascularization for the treatment of intracranial atherosclerotic disease. Neurol Res. 2002; 24: 337–346.

Vajda

Schmid

Güthe

. The modified Bosemethod for the endovascular treatment of intracranial atherosclerotic arterial stenoses using the Enterprise stent. Neurosurgery. 2011; 70: 91–101.

Chimowitz

Lynn

Derdeyn

. for the SAMMPRIS Trial Investigators. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011; 365: 993–1003.

Guidelines for management of ischaemic stroke and transient ischaemic attack 2008: ESO Writing Committee. Cerebrovasc Dis. 2008; 25: 257–507.

Castaño

Serena

Davalos

. Use of the new SOLITAIRE AB device for mechanical thrombectomy when MERCI clot retriever has failed to remove the clot. Intervent Neuroradiol. 2009; 15: 209–214.

Castaño

Dorado

Guerrero

. Mechanical thrombectomy with the Solitaire AB device in large artery occlusions of the anterior circulation: A pilot study. Stroke. 2010; 41: 1836–1840.

Akins

Pilgram

Cross

III . Natural history of stenosis from intracranial atherosclerosis by serial angiography. Stroke. 1998, 29: 433–438.

10.

Ingall

Homer

Baker

Jr . Predictors of intracranial carotid artery atherosclerosis: Duration of cigarette smoking and hypertension are more powerful than serum lipid levels. Arch Neurol. 1991; 48: 687–691.

11.

Marzewski

Furlan

St Louis

. Intracranial internal carotid artery stenosis: Long-term prognosis. Stroke. 1982; 13: 821–824.

12.

Kasner

Chimowitz

Lynn

. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006; 113: 555–563.

13.

Chimowitz

Lynn

Howlett-Smith

. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005; 352: 1305–1316.

14.

Kern

Steinke

Daffertshofer

. Stroke recurrences in patients with symptomatic vs asymptomatic middle cerebral artery disease. Neurology. 2005; 65: 859–864.

15.

Bauer

Boulos

Meyer

. Natural history and surgical treatment of occlusive cerebrovascular disease evaluated by serial arteriography. Am J Roentgenol Radium Ther Nucl Med. 1968; 104: 1–17.

16.

Craig

Mageuro

Watridge

. Intracranial internal carotid artery stenosis. Stroke. 1982; 13: 825–828.

17.

Awad

Furlan

Little

. Changes in intracranial stenotic lesions after extracranial-intracranial bypass surgery. J Neurosurg. 1984; 60: 771–776.

18.

Fisher

Gore

Okabe

. Atherosclerosis of the carotid and vertebral arteries: Extracranial and intracranial. J Neuropathol Exp Neurol. 1965; 24: 455–476.

19.

Moosy

. Cerebral infarcts and the lesions of intracranial and extracranial atherosclerosis. Arch Neurol. 1966; 14: 124–128.

20.

Caplan

Gorelick

Hier

. Race, sex, and occlusive cerebrovascular disease: A review. Stroke. 1986; 17: 648–655.

21.

Chimowitz

Kokkinos

Strong

. for the Warfarin-Aspirin Symptomatic Intracranial Disease Study Group. The warfarin-aspirin symptomatic intracranial disease study. Neurology. 1995; 45: 1488–1493.

22.

Nahab

Kingston

Frankel

. Early aggressive medical management for patients with symptomatic intracranial stenosis. J Stroke Cerebrovasc Dis. 2011 Jul 25. [Epub ahead of print].

23.

The EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke: Results of an international randomized trial. N Engl J Med. 1985; 313: 1191–1200.

24.

Higashida

Tsai

Halbach

. Cerebral percutaneous transluminal angioplasty. J Heart Dis Stroke. 1993; 2: 497–502.

25.

Ferguson

RDG

Ferguson

Lee

. Endovascular revascularization therapy in cerebral athero-occlusive disease: Angioplasty and stents, systemic and local thrombolysis. Neurosurg Clin N Am. 1994; 5: 511–527.

26.

Higashida

Halbach

Tsai

. Interventional neurovascular techniques for cerebral revascularization in the treatment of stroke. Am J Roentgenol. 1994; 163: 793–800.

27.

Clark

Barnwell

Nesbit

. Safety and efficacy of percutaneous transluminal angioplasty for intracranial atherosclerotic stenosis. Stroke. 1995; 26: 1200–1204.

28.

Houdart

Ricolfi

Brugieres

. Percutaneous transluminal angioplasty of atherosclerotic basilar artery stenosis. Neuroradiology. 1996; 38: 383–385.

29.

Terada

Higashida

Halbach

. Transluminal angioplasty for arteriosclerotic disease of the distal vertebral and basilar arteries. J Neurol Neurosurg Psychiatry. 1996; 60: 377–381.

30.

Levy

Mehta

Gupta

. Self-expanding stents for recanalization of acute cerebrovascular occlusions. Am J Neuroradiol. 2007; 28: 816–22.

31.

Piotin

Blanc

Kothimbakam

. Primary basilar artery stenting: Immediate and long-term results in one patient. Am J Roentgenol. 2000; 175: 1367–1369.

32.

Summary of risk and probable benefit: Humanitarian Use Device Designation H050001. August 3, 2005. Available at: http://www.fda.gov/cdrh/pdf5/h050001b.pdf.

33.

Suh

Kim

Choi

. Intracranial stenting of severe symptomatic intracranial stenosis: Results of 100 consecutive patients. Am J Neuroradiol. 2008; 29: 781–785.

34.

Bose

Hartmann

Henkes

. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: The Wingspan study. Stroke. 2007; 38: 1531–1537.

35.

Fiorella

Levy

Turk

. US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: Periprocedural results. Stroke. 2007; 38: 881–887.

36.

Zaidat

Klucznik

Alexander

. for the NIH Multicenter Wingspan Intracranial Stent Registry Study Group: The NIH registry on use of the Wingspan stent for symptomatic 70–99% intracranial arterial stenosis. Neurology. 2008; 70: 1518–1524.

37.

Jiang

Cheng-Ching

Abou-Chebl

. Multicenter analysis of stenting in symptomatic intracranial atherosclerosis. Neurosurgery. 2011; 70: 25–31.

38.

Henkes

Miloslavski

Lowens

. Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (Wing-Span). Neuroradiology. 2005; 47: 222–228.

39.

Lefkovits

Ivanhoe

Califf

. Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction: EPIC investigators. Am J Cardiol. 1996; 77: 1045–1051.

40.

Wallace

Furlan

Moliterno

. Basilar artery rethrombosis: Successful treatment with platelet glycoprotein IIB/ IIIA receptor inhibitor. Am J Neuradiol. 1997; 18: 1257–1260.

41.

The EPISTENT investigators. Evaluation of platelet IIb/IIIa inhibitor for stenting: Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet. 1998; 352: 87–92.

42.

Lincoff

Califf

Moliterno

. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/ IIIa receptors: Evaluation of platelet IIb/IIIa inhibition in stenting investigators. N Engl J Med. 1999; 341: 319–327.

43.

Mega

Wiviott

. Cytochrome P-450 polymorphisms and response to Clopidogrel. N Engl J Med. 2009; 360: 354–362.